about
Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick GetawayCytomegalovirus antivirals and development of improved animal modelsActivation of Virus-specific Memory B Cells in the Absence of T Cell HelpAntigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Arms Race between Enveloped Viruses and the Host ERAD MachineryExploiting viral natural history for vaccine developmentFast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genesSurfactant protein A binding to cytomegalovirus proteins enhances virus entry into rat lung cells.Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule.Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challengeUsing the nonhuman primate model of HCMV to guide vaccine developmentDevelopment and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvantStrain-specific neutralization of human cytomegalovirus isolates by human sera.Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycoprotein envelope complex of human cytomegalovirus.Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.Characterization of the elements and proteins responsible for interferon-stimulated gene induction by human cytomegalovirus.Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.Enzyme-linked immunosorbent assay for measurement of cytomegalovirus glycoprotein B antibody in serum.Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathwayMolecular pathogenesis of human cytomegalovirus infection.Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirusDetection of human cytomegalovirus in different histological types of gliomas.Cytomegalovirus blood viral load and hearing loss in young children with congenital infection.The diversity of retrotransposons and the properties of their reverse transcriptases.Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.A protein-based therapeutic for human cytomegalovirus infectionComplete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gOHuman cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells.Viral Glycoprotein Complex Formation, Essential Function and Immunogenicity in the Guinea Pig Model for CytomegalovirusRecombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen.A Homolog Pentameric Complex Dictates Viral Epithelial Tropism, Pathogenicity and Congenital Infection Rate in Guinea Pig CytomegalovirusAntibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin.The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.Active human cytomegalovirus infection and glycoprotein b genotypes in brazilian pediatric renal or hematopoietic stem cell transplantation patients.Viral binding-induced signaling drives a unique and extended intracellular trafficking pattern during infection of primary monocytes.A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection.Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells.
P2860
Q26745798-03D436E0-0899-485D-8CED-08F9B9E4013EQ27000998-55AFA7FC-AB74-4374-BFA7-3193D9FD62C5Q27485181-347DF7B4-F9DB-4503-98A3-0EA31EB23C45Q27632371-395BB774-D73A-4F9D-8307-B77880607DEBQ27692570-0C883266-F621-4DC1-B0E3-0D4C25BA38B2Q28078319-5131176F-4BAF-4AB6-93A4-DE613A621A21Q28081817-C66B2D05-9CFF-4BEF-A25D-83EE36401A62Q30656734-018038AC-70B7-49B0-934D-A4E253F383CDQ30883047-B61D0C9F-47DF-4543-8EBF-5B7D2E79B501Q31035724-7FB5B06F-9298-4A1E-AB58-148F8F2B8CB3Q33551402-F013E6F0-C585-4CA0-8A26-8D26380D20BAQ33584739-8204E26E-6BED-4184-B70D-E13E9E07500CQ33585524-3D062082-21E6-4F4E-A4EC-5FE2CDB2D41AQ33640031-30320D2D-FD55-4179-A02C-27D780D8968AQ33646932-3D4E6FB4-3D92-4CAB-8DE1-3DF7C9165986Q33707484-855535F8-A964-4B83-BA6E-2879DF1F0672Q33724235-6FD3B6A9-0715-4742-B217-E15C8FD56D60Q33793463-8018250F-83BB-4A38-8024-53CABD59D633Q33825662-8D6F1AB7-73B6-48CC-B6EC-C726FD6CBDD3Q33957986-5B21B6BA-558C-422A-97B2-DAF82812D0A6Q34294817-3944F04E-4782-4FAD-9250-CD1A2A3CFF34Q34328645-3BABD940-9AB7-44E2-A206-91902E562760Q34402501-A1BA52FD-0D5A-45A3-A1C6-8EC99AFFFBDBQ34549638-5706B218-D2DA-4271-B889-6D8165E47ACCQ34588175-343C0C9A-4BCA-4222-99DE-70C5697C742BQ34975513-BF03489B-D718-425B-963F-C817E22B0061Q35083082-C7F0404A-F5BD-448C-90C4-40665183D1FEQ35214272-F20B78AC-00F8-41CD-BDC5-AD0CA76EC23EQ35673697-90E4F888-BD55-429A-AF70-C9A5A299FE2DQ35743884-969C6056-B103-478F-9909-762184A74B92Q35849244-37877283-8A76-4F0C-B2DC-C18FFE0AD2ABQ36069719-76121F5F-23D3-4605-92BE-A5027BF2776CQ36155456-930BD76C-BC54-45BB-B129-038C9BB0FD1FQ36302615-B0BC3473-D4D6-48CE-BBA8-0E0BB8D379CEQ37004820-BC36C553-29CD-4B40-AED7-982B892955CBQ37159472-6FC1C39F-3715-4683-AE54-70E5230D2BD6Q37161687-6A875D5B-2856-4AFB-9DD7-D1AF68EA3E3BQ37182670-4D1A8B1B-D868-466F-B6AA-F0BC6AB490F1Q37243886-603B4630-8DC0-41A0-87A7-6F3056F585E8Q37252609-03DCD496-0BA6-4BFD-91F4-94EAF062BA42
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Human cytomegalovirus glycoproteins.
@en
type
label
Human cytomegalovirus glycoproteins.
@en
prefLabel
Human cytomegalovirus glycoproteins.
@en
P356
P1433
P1476
Human cytomegalovirus glycoproteins.
@en
P304
P356
10.1159/000150510
P577
1996-01-01T00:00:00Z